Insights Into Integra Lifesciences Holdings Corp (IART) Exposure By Institutions

Bethany Hill

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Integra Lifesciences Holdings Corp is listed on the NASDAQ in the Healthcare sector while operating in the Medical Devices industry. The current market capitalization of Integra Lifesciences Holdings Corp is $960.41M. A total of 0.86 million shares were traded on the day, compared to an average of 1.20M shares.

In the most recent transaction, GRAVES JEFFREY A bought 9,000 shares of IART for 11.35 per share on Nov 05 ’25. After the transaction, the Director now owns 41,086 company shares. In a previous transaction on Dec 03 ’24, Schwartz Eric sold 4,070 shares at 24.59 per share. IART shares that EVP, Chief Legal Officer & Sec owns now total 59,511.

Among the insiders who bought shares, Schwartz Eric acquired of 4,070 shares on Dec 03 ’24 at a per-share price of $24.59. In another insider transaction, McBreen Michael J. sold 1,700 shares at $24.16 per share on Dec 02 ’24. Company shares held by the EVP & President, CSS now total 56,182.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, IART has a high of $27.13 and a low of $10.87.

As of this writing, IART has an earnings estimate of $0.8 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $0.82 per share and a lower estimate of $0.78. The company reported an EPS of $0.97 in the last quarter

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. IART’s latest balance sheet shows that the firm has $513.45M in Cash & Short Term Investments as of fiscal 2021. There were $1.65B in debt and $340.02M in liabilities at the time. Its Book Value Per Share was $13.33, while its Total Shareholder’s Equity was $1.68B.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IART is Buy with a score of 3.00.

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.